Back to search
Borderline Lepromatous Leprosy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Borderline Lepromatous Leprosy trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Borderline Lepromatous Leprosy trials you may qualify for\*\*Brief Summary\*\* Leprosy is a chronic granulomatous infectious disease caused by \*Mycobacterium leprae\* or \*Mycobacterium lepromatosis\*, characterized…
This trial aims to evaluate the efficacy, tolerability and safety of adjunct metformin added to standard-of-care multi-drug therapy (MDT) in patients with multi…
The goal of this observational retrospective study is to characterize the epidemiologic, clinical, diagnostic, and therapeutic features of Hansen's disease case…
* Measurement of plasma irisin level in leprosy patients. * Correlation of plasma irisin level between leprosy patients and healthy controls. * Correlation of p…
The purpose of this study is to assess the efficacy of an 8-week bedaquiline monotherapy regimen in participants with treatment-naive, multibacillary (MB) lepro…